|
US4169079A
(en)
|
1977-10-24 |
1979-09-25 |
Iwao Tabushi |
Polystyrene based polymers containing cyclodextrin derivatives, metal complexes of the same, and process for the production of the same
|
|
US5574027A
(en)
|
1989-11-22 |
1996-11-12 |
Bernstein; Lawrence R. |
Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
|
|
US5234933A
(en)
|
1991-10-31 |
1993-08-10 |
Board Of Governors Of Wayne State University And Vanderbilt University |
Cyclic hydroxamic acids
|
|
DE4210332C1
(https=)
|
1992-03-30 |
1993-07-15 |
Gruenenthal Gmbh, 5100 Aachen, De |
|
|
US5814666A
(en)
|
1992-04-13 |
1998-09-29 |
The United States As Represented By The Department Of Health And Human Services |
Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
|
|
US5238832A
(en)
|
1992-06-08 |
1993-08-24 |
Board Of Governors Of Wayne State University |
Aryl aliphatic acids
|
|
US5632981A
(en)
|
1992-08-24 |
1997-05-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
US5405919A
(en)
|
1992-08-24 |
1995-04-11 |
The United States Of America As Represented By The Secretary Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
|
|
US5691423A
(en)
|
1992-08-24 |
1997-11-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polysaccharide-bound nitric oxide-nucleophile adducts
|
|
US6200558B1
(en)
|
1993-09-14 |
2001-03-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
US5650447A
(en)
|
1992-08-24 |
1997-07-22 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Nitric oxide-releasing polymers to treat restenosis and related disorders
|
|
US5910316A
(en)
|
1992-08-24 |
1999-06-08 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Use of nitric oxide-releasing agents to treat impotency
|
|
US5525357A
(en)
|
1992-08-24 |
1996-06-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
|
|
CA2173738A1
(en)
|
1993-10-08 |
1995-04-20 |
James B. Mitchell |
Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers
|
|
US5840759A
(en)
|
1993-10-08 |
1998-11-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
|
|
JPH09508097A
(ja)
|
1993-11-02 |
1997-08-19 |
アメリカ合衆国 |
虚血再灌流傷害における保護剤としての酸化窒素放出化合物の使用
|
|
CA2205564C
(en)
|
1994-11-22 |
2006-07-11 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
|
|
US5714511A
(en)
|
1995-07-31 |
1998-02-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
|
|
US5770645A
(en)
|
1996-08-02 |
1998-06-23 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
|
US6232434B1
(en)
|
1996-08-02 |
2001-05-15 |
Duke University Medical Center |
Polymers for delivering nitric oxide in vivo
|
|
US20030093143A1
(en)
|
1999-03-01 |
2003-05-15 |
Yiju Zhao |
Medical device having surface depressions containing nitric oxide releasing compound
|
|
JP4285775B2
(ja)
|
1996-09-27 |
2009-06-24 |
アメリカ合衆国 |
Ｏ▲上２▼―アリール化またはｏ▲上２▼―グリコシル化１―置換ジアゼン―１―イウム―１，２―ジオレート類およびｏ▲上２▼―置換１―［（２―カルボキシラト）ピロリジン―１―イル］ジアゼン―１―イウム―１，２―ジオレート類
|
|
CA2266908C
(en)
|
1996-09-27 |
2010-07-20 |
Joseph E. Saavedra |
O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
|
|
NO305033B1
(no)
|
1997-05-09 |
1999-03-22 |
Algipharma As |
Fremgangsmate for fremstilling av uronsyreblokker fra alginat
|
|
US6180082B1
(en)
|
1997-11-24 |
2001-01-30 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Method to enhance tissue accumulation of radiolabeled compounds
|
|
US6207855B1
(en)
|
1998-06-23 |
2001-03-27 |
Duke University Medical Center |
Stable no-delivering compounds
|
|
US6261594B1
(en)
|
1998-11-25 |
2001-07-17 |
The University Of Akron |
Chitosan-based nitric oxide donor compositions
|
|
CA2726789A1
(en)
|
2000-02-05 |
2001-11-08 |
Theravance, Inc. |
Cyclodextrin containing glycopeptide antibiotic compositions
|
|
JP2002179647A
(ja)
|
2000-12-11 |
2002-06-26 |
Kikkoman Corp |
ニコチアナミン又はニコチアナミン含有物の製造法
|
|
AUPR879601A0
(en)
|
2001-11-09 |
2001-12-06 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
|
AU2003226603A1
(en)
|
2002-04-19 |
2003-11-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
|
|
US20040038947A1
(en)
|
2002-06-14 |
2004-02-26 |
The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services |
Method of treating ischemia/reperfusion injury with nitroxyl donors
|
|
US6949530B2
(en)
*
|
2002-07-18 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same
|
|
NO20023581D0
(no)
|
2002-07-26 |
2002-07-26 |
Fmc Biopolymer As |
Nye mutantstammer av Pseudomonas fluorescens og varianter derav, metoder for produksjon og bruk derav til produksjon avalginat
|
|
NO335366B1
(no)
|
2002-07-26 |
2014-12-01 |
Algipharma As |
Mutantstamme Pf201 av Pseudomonas fluorescens og anvendelse derav i alginatproduksjon,samt fremgangsmåte for fremstilling derav.
|
|
ES2377318T3
(es)
|
2002-09-06 |
2012-03-26 |
Cerulean Pharma Inc. |
Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
|
|
US20050009789A1
(en)
|
2003-05-13 |
2005-01-13 |
The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Service |
Cyclooxygenase inhibition with nitroxyl
|
|
JP2005047979A
(ja)
|
2003-07-30 |
2005-02-24 |
Dainippon Ink & Chem Inc |
多分岐ポリマーの製造方法、及び多分岐ポリマー
|
|
US20050265956A1
(en)
|
2004-01-12 |
2005-12-01 |
Ye Liu |
Polyalkyleneimine-graft-biodegradable polymers for delivery of bioactive agents
|
|
US20050265958A1
(en)
*
|
2004-05-14 |
2005-12-01 |
West Jennifer L |
Nitric oxide releasing compositions and associated methods
|
|
US8097343B2
(en)
*
|
2004-08-31 |
2012-01-17 |
Triton Systems, Inc. |
Functionalized dendritic polymers for the capture and neutralization of biological and chemical agents
|
|
WO2006083678A2
(en)
|
2005-01-28 |
2006-08-10 |
Pinnacle Pharmaceuticals, Inc. |
β-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS
|
|
EP1888510A4
(en)
|
2005-05-27 |
2013-01-16 |
Univ North Carolina |
NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
|
|
AU2014221249B2
(en)
*
|
2005-05-27 |
2016-05-05 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
|
|
GB0515550D0
(en)
|
2005-07-29 |
2005-09-07 |
Univ Strathclyde |
Inactivation of staphylococcus species
|
|
AU2006309212B2
(en)
|
2005-10-31 |
2011-09-15 |
Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services |
Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates
|
|
JP2009523584A
(ja)
|
2006-01-24 |
2009-06-25 |
ミリメッド・アクティーゼルスカブ |
Ｐｈ依存性薬物放出を有する医療デバイス
|
|
US7854923B2
(en)
|
2006-04-18 |
2010-12-21 |
Endomedix, Inc. |
Biopolymer system for tissue sealing
|
|
GB0707096D0
(en)
|
2007-04-12 |
2007-05-23 |
Ntnu Technology Transfer As |
Method
|
|
CN101049513B
(zh)
|
2007-05-13 |
2010-05-19 |
刘万顺 |
水溶性壳聚糖基纤维止血愈创材料及其制备方法和应用
|
|
ITMI20071341A1
(it)
|
2007-07-05 |
2009-01-06 |
Fidia Farmaceutici |
Derivati di acido ialuronico contenenti gruppi in grado di rilasciare no
|
|
US8399005B2
(en)
|
2007-10-12 |
2013-03-19 |
University Of North Carolina At Chapel Hill |
Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
|
|
KR101690631B1
(ko)
|
2007-11-27 |
2017-01-09 |
알지파마 아이피알 에이에스 |
바이오필름 퇴치에 있어서의 알기네이트 올리고머의 용도
|
|
US20090222088A1
(en)
|
2008-02-29 |
2009-09-03 |
Medtronic Vascular, Inc. |
Secondary Amine Containing Nitric Oxide Releasing Polymer Composition
|
|
US20090232863A1
(en)
|
2008-03-17 |
2009-09-17 |
Medtronic Vascular, Inc. |
Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers
|
|
EP2260060A4
(en)
|
2008-04-01 |
2013-01-16 |
Univ Cornell |
ORGANIC SOLUBLE CHITOSA SALT AND CHITOSAN DERIVED BIOMATERIALS MANUFACTURED THEREFROM
|
|
AU2009299118B2
(en)
|
2008-10-03 |
2015-12-17 |
Glycan Biosciences Llc |
Anionic conjugates of glycosylated bacterial metabolite
|
|
WO2010096320A2
(en)
|
2009-02-18 |
2010-08-26 |
Bezwada Biomedical, Llc |
Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
|
|
GB0904941D0
(en)
|
2009-03-23 |
2009-05-06 |
Ntnu Technology Transfer As |
Composition
|
|
US20120107229A1
(en)
|
2009-04-15 |
2012-05-03 |
Xuefei Huang |
Novel nano-probes for molecular imaging and targeted therapy of diseases
|
|
US9539233B2
(en)
|
2009-05-04 |
2017-01-10 |
Aridis Pharmaceuticals Inc. |
Gallium formulation for the treatment and prevention of infectious diseases
|
|
GB0909557D0
(en)
|
2009-06-03 |
2009-07-15 |
Algipharma Ipr As |
Anti-microbial alginate oligomers
|
|
GB0909529D0
(en)
|
2009-06-03 |
2009-07-15 |
Algipharma Ipr As |
Alginate oligomers for the inhibition of microbial adherence to surfaces
|
|
BRPI1011248A2
(pt)
|
2009-06-03 |
2016-03-22 |
Algipharma As |
métodos in vitro ou ex vivo de superação de resitência a pelo menos um antibiótico, para combate de contaminação de um sítio e melhora da eficácia de um antibiótico de macrolídeo para inibir o crescimento de bactéria mdr gram negativa, uso de um oligômero de alginato e produto
|
|
US9957341B2
(en)
|
2009-06-09 |
2018-05-01 |
William Chambers |
Biodegradable absorbent material and method of manufacture
|
|
CA2767163A1
(en)
*
|
2009-06-15 |
2010-12-23 |
Wayne State University |
Dendrimer based nanodevices for therapeutic and imaging purposes
|
|
CA2671595A1
(en)
|
2009-07-09 |
2011-01-09 |
Ping I. Lee |
Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes
|
|
US8551456B2
(en)
|
2010-03-05 |
2013-10-08 |
University Of Dayton |
Combination therapy and methods for treating bacterial biofilms
|
|
WO2011116336A1
(en)
|
2010-03-19 |
2011-09-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
|
|
KR101272351B1
(ko)
|
2010-04-23 |
2013-06-07 |
이화여자대학교 산학협력단 |
새로운 카나마이신 화합물, 카나마이신 생산 스트렙토마이세스 속 미생물 및 카나마이신의 생산 방법
|
|
KR101255337B1
(ko)
|
2010-10-04 |
2013-04-16 |
한국과학기술연구원 |
온도 감응성 합성 고분자를 이용한 일산화질소 전달체
|
|
WO2012116177A2
(en)
|
2011-02-24 |
2012-08-30 |
Colorado State University Research Foundation |
Materials for modulating biological responses and methods of making
|
|
ES2658897T3
(es)
*
|
2011-08-24 |
2018-03-12 |
Novan, Inc. |
Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
|
|
GB201116010D0
(en)
|
2011-09-15 |
2011-10-26 |
Algipharma As |
Use of alginate oligomers to enhance the effects of antifungal agents
|
|
US9017653B2
(en)
|
2012-06-14 |
2015-04-28 |
The Board Of Regents Of The University Of Texas System |
Nitric oxide-releasing compositions and methods
|
|
EP2885323B1
(en)
*
|
2012-08-17 |
2023-08-30 |
The University of North Carolina At Chapel Hill |
Water soluble nitric oxide-releasing polyglucosamines and uses thereof
|
|
BR112015021388A2
(pt)
|
2013-03-08 |
2017-07-18 |
Allergan Inc |
conjugados esteroides de ciclosporina a
|
|
GB201322777D0
(en)
|
2013-12-20 |
2014-02-05 |
Algipharma As |
Use of alginate oligomers as blood anticoagulants
|
|
MX2016008304A
(es)
|
2013-12-23 |
2017-01-09 |
Norwegian Univ Of Science And Tech |
Usos de oligouronatos en el tratamiento de cancer.
|
|
KR20160119259A
(ko)
|
2014-02-28 |
2016-10-12 |
알지파마 에이에스 |
낭포성 섬유증 및 cftr 이온 채널의 기능 결함과 관련된 기타 병태의 치료제로서 알기네이트 올리고머의 용도
|
|
GB201415381D0
(en)
|
2014-08-29 |
2014-10-15 |
Algipharma As |
Inhalable powder formulations of alginate oligomers
|
|
EP3215140A4
(en)
|
2014-11-06 |
2018-05-02 |
The Arizona Board of Regents On Behalf of the University of Arizona |
Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
|
|
GB201504878D0
(en)
|
2015-03-23 |
2015-05-06 |
Algipharma As |
Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion
|
|
US11170451B2
(en)
|
2015-10-02 |
2021-11-09 |
Not So Forgetful, LLC |
Apparatus and method for providing gift recommendations and social engagement reminders, storing personal information, and facilitating gift and social engagement recommendations for calendar-based social engagements through an interconnected social network
|
|
GB201517639D0
(en)
|
2015-10-06 |
2015-11-18 |
Algipharma As |
Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract
|
|
CN106046382B
(zh)
*
|
2016-05-25 |
2018-10-09 |
暨南大学 |
一种装载一氧化氮的阳离子聚合物及其制备方法和应用
|
|
EP3523367A4
(en)
|
2016-10-07 |
2020-06-03 |
The University Of North Carolina At Chapel Hill |
S-NITROSOTHIOL-MEDIATED HYPERBRANCHED POLYESTER
|
|
US11072668B2
(en)
|
2017-01-03 |
2021-07-27 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
|
|
JP7403152B2
(ja)
*
|
2017-03-28 |
2023-12-22 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
生分解可能な抗菌性スキャフォールドとしての一酸化窒素放出性ポリアミノグリコシドおよびそれに関する方法背景
|
|
AU2018369760B2
(en)
|
2017-11-15 |
2025-01-02 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto
|
|
WO2019173539A1
(en)
|
2018-03-06 |
2019-09-12 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
|
|
US11102301B2
(en)
|
2018-07-12 |
2021-08-24 |
Sap Se |
PCA-based scoring of the similarity of damage patterns of operational assets
|
|
JP7645546B2
(ja)
|
2018-12-28 |
2025-03-14 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
一酸化窒素放出抗菌性ポリマーおよびそれから製造された足場、ならびにそれに関する方法
|